• Collaboration for Early Detection of Alzheimer’s Biomarkers Announced
    The product used for research (MALDI-TOF Mass Spectrometry ‘AXIMA Assurance’).

Mass Spectrometry & Spectroscopy

Collaboration for Early Detection of Alzheimer’s Biomarkers Announced

Jun 05 2020

Shimadzu introduces the collaboration with the Clinical Laboratory and Proteomics Platform of the CHU University Hospital of Montpellier, France. With the team of professors Sylvain Lehmann and Christophe Hirtz, they focus on MS based blood amyloid-beta analysis for early screening of amyloid-positive subjects. The cooperation plans to conduct a joint cohort study from the Memory Resources and Research Center (Professor Audrey Gabelle) to evaluate whether this simple blood analysis method enables early and accurate prediction of amyloid pathology in the brain with an easy-to-acquire blood sample.

Unlike conventional positron emission tomography (PET) imaging and cerebrospinal fluid (CSF) testing methods, Shimadzu’s blood amyloid-beta analysis method is minimally invasive and suitable for large-scale deployment. It is a new-approach blood analysis capable of being used for the research of detecting abnormal amyloid-beta concentration which can be a marker for amyloid pathology in the brain.

These new blood-based biomarkers were discovered in 2014 by Shimadzu and the Japanese National Center for Geriatrics and Gerontology (NCGG). Although the screening analysis is Research Use Only and cannot diagnose Alzheimer’s disease, it is ideal for opening the door to new advancements in research, identifying suitable candidates for clinical trials and helping pharmaceutical company to test candidate drugs.

The blood analysis works using a combination of immunoprecipitation and MALDI-TOF mass spectrometry (IP-MS). This technique was first established by a team of scientists including Shimadzu’s Koichi Tanaka, who was awarded the Nobel Prize in Chemistry in 2002 for developing a method for mass spectrometric analysis of biological macromolecules.

The CHU of Montpellier is part of Shimadzu’s European Innovation Center (EUIC) program. The EUIC merges the cutting-edge analytical technologies of Shimadzu with game-changing topics and expertise in markets and science covered by opinion leaders, strategic thinkers and scientific experts in order to create new solutions for tomorrow.

More information online


Digital Edition

Lab Asia December 2021

December 2021

Chromatography - A novel approach to the analysis of alcohols in hydrocarbon streams by gas chromatography - Smart Evaporation Solutions for Academic Labs - Streamlined Solutions for Natural P...

View all digital editions

Events

Nano Tech 2022

Jan 26 2022 Tokyo, Japan

AUTOMATICON

Jan 26 2022 Warsaw, Poland

SLAS 2022

Feb 05 2022 Boston, USA & online

Asia Pharma Expo/Asia Lab Expo

Mar 03 2022 Dhaka, Bangladesh

SIAF Guangzhou

Mar 03 2022 Guanghzou, China

View all events